These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32528121)

  • 1. Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.
    Anurathapan U; Apiwattanakul N; Pakakasama S; Pongphitcha P; Thitithanyanont A; Pasomsub E; Hongeng S
    Bone Marrow Transplant; 2020 Dec; 55(12):2359-2360. PubMed ID: 32528121
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful Hematopoietic Stem Cell Transplantation from a Donor Sibling Infected with SARS-CoV-2 Using Molnupiravir Prophylaxis.
    Mandacı Şanlı N; Akyol G; Türe Yüce Z; Keklik M; Ünal A
    Turk J Haematol; 2023 May; 40(2):135-136. PubMed ID: 37183568
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematopoietic Stem Cell Transplantation to a Patient with Acute Myeloid Leukemia from a Sibling Donor Positive for SARS-CoV-2 by RT-PCR Test.
    Koç A; Doğru Ö; Eker N; Tufan Taş B; Şenay RE
    Turk J Haematol; 2022 Jun; 39(2):150-151. PubMed ID: 35470653
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute exacerbation of graft-versus-host disease following SARS-CoV2 infection after hematopoietic stem cell transplant in two pediatric patients.
    Choe M; Martinez C; Krance R; Doherty E
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29661. PubMed ID: 35293671
    [No Abstract]   [Full Text] [Related]  

  • 5. The Use of SARS-CoV-2-Positive Donors in Hematopoietic Stem Cell Transplantation.
    Cheng M; Qian C; Zhou H; Cao Y; Xu M; Zhang T; Xue S; Sun A
    Transplant Proc; 2023 Oct; 55(8):1810-1814. PubMed ID: 37236865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
    Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19.
    Lázaro Del Campo P; de Paz Arias R; Ramírez López A; de la Cruz Benito B; Humala Barbier K; Sánchez Vadillo I; López de la Guía A; de Soto Álvarez T; Jiménez Yuste V; Canales Albendea M
    Transfus Apher Sci; 2020 Dec; 59(6):102921. PubMed ID: 32928663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of donor and recipient characteristics on graft-versus-host disease and survival in HLA-matched sibling hematopoietic stem cell transplantation.
    Zhang H
    Transfus Apher Sci; 2020 Jun; 59(3):102743. PubMed ID: 32139282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive transfer of functional SARS-COV-2-specific immunity from donor graft to hematopoietic stem cell transplant recipients.
    La Rosa C; Chiuppesi F; Park Y; Gendzekhadze K; Zhou Q; Faircloth K; Kaltcheva T; Johnson D; Ortega Francisco S; Amanam I; Otoukesh S; Pullarkat VA; Nakamura R; Diamond DJ; Forman SJ; Al Malki MM
    Am J Hematol; 2022 Nov; 97(11):E404-E407. PubMed ID: 36053823
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Salvatore D; Labopin M; Ruggeri A; Battipaglia G; Ghavamzadeh A; Ciceri F; Blaise D; Arcese W; Sociè G; Bourhis JH; Van Lint MT; Bruno B; Huynh A; Santarone S; Deconinck E; Mohty M; Nagler A
    Haematologica; 2018 Aug; 103(8):1317-1328. PubMed ID: 29748438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable Outcome with a Faster Engraftment of Optimized Haploidentical Hematopoietic Stem Cell Transplantation Compared with Transplantations from Other Donor Types in Pediatric Acquired Aplastic Anemia.
    Kim H; Im HJ; Koh KN; Kang SH; Yoo JW; Choi ES; Cho YU; Jang S; Park CJ; Seo JJ
    Biol Blood Marrow Transplant; 2019 May; 25(5):965-974. PubMed ID: 30639824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid-19 pandemic.
    Schmidt AH; Buk D; Bernas SN; Mengling T; Neujahr E; van den Brink MRM
    Am J Hematol; 2021 Mar; 96(3):E91-E92. PubMed ID: 33368593
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage.
    Szer J; Weisdorf D; Querol S; Foeken L; Madrigal A
    Bone Marrow Transplant; 2020 Oct; 55(10):2043-2044. PubMed ID: 32203269
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
    Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
    Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Mamez AC; Pradier A; Giannotti F; Petitpas A; Urdiola MF; Vu DL; Masouridi-Levrat S; Morin S; Dantin C; Clerc-Renaud D; Eberhardt CS; Kaiser L; Simonetta F; Chalandon Y
    Bone Marrow Transplant; 2021 Dec; 56(12):3094-3096. PubMed ID: 34584239
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
    Lazaryan A; Weisdorf DJ; DeFor T; Brunstein CG; MacMillan ML; Bejanyan N; Holtan S; Blazar BR; Wagner JE; Arora M
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):134-40. PubMed ID: 26365153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of transmission of SARS-CoV-2 by platelet transfusion from a COVID-19-positive donor in a hematopoietic stem cell transplantation patient.
    Essa MF; Elbashir E; Batarfi K; Alharbi M
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28658. PubMed ID: 32813297
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis.
    Musiu P; Quattrocchi L; Barberi W; Della Starza I; Elia L; De Novi LA; Petrucci L; De Luca G; Di Rocco A; La Rocca U
    Leuk Lymphoma; 2022 Feb; 63(2):499-502. PubMed ID: 34693859
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of matched sibling, unrelated and haploidentical donors in hematopoietic stem cell transplantation. A real-world experience from the Argentine Group for Bone Marrow Transplantation and Cell Therapy (GATMO-TC).
    Trucco JI; Berro M; Basquiera AL; García P; Yantorno S; Palmer S; Requejo A; Vitriú A; Bentolila G; Rivas MM; Ferini G; García JJ; Milone J; Stemmelin G; Jaimovich G; Foncuberta C; Martínez Rolón J; Kusminsky GD;
    Medicina (B Aires); 2020; 80(6):654-662. PubMed ID: 33254110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.